‘As a researcher strongly committed to driving Personalised Healthcare forward, I appreciate some of the distinct advantages of having both Pharmaceuticals and Diagnostics under one roof .’
Scientific/Biomarker expert
Dr Shirin Khambata Ford
‘We see tremendous changes in our tasks. With Personalised Healthcare, diagnostic services gain relevance rapidly since our test results become integral factors for the development of modern treatment strategies.’
Medical laboratory scientist
Dr José Gilberto Vieira
‘It’s a very exciting time for us. We are all aware that we are entering a new era of skin cancer treatment!’
Physician
Dr Caroline Robert
‘In my view, Personalised Healthcare will be the only way of husbanding our resources in a way that makes good business sense!’
Insurance Executive
Prof. Thomas Szucs
‘The option of targeted treatment gave me hope and a better quality of life!’
Patient
Doretha 'Dee' Burrell
‘The immediate combination of diagnosis, therapy and monitoring of treatment success in hepatitis B infection is a major step forward. This increases the benefits for our patients enormously!’
Investigator
Prof. Henry Lik-Yuen Chan
Annual Report 2011
- Annual Report
- Business Report (8.1 MB)
- Finance Report (9.7 MB)
- Order printed copy
- Investor Call
- Media Conference
Find Roche in your country
Media Releases
- February 08, 2012
FDA grants Roche's pertuzumab Priority Review for previously untreated HER2-positive metastatic breast cancer - February 08, 2012
Roche disappointed by the actions of Illumina, Inc.'s Board of Directors